TY - JOUR AU - Nichols, E. AU - Szoeke, C. E. I. AU - Vollset, S. E. AU - Abbasi, N. AU - Abd-Allah, F. AU - Abdela, J. PY - 2019 DA - 2019// TI - Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 JO - Lancet Neurol VL - 18 UR - https://doi.org/10.1016/S1474-4422(18)30403-4 DO - 10.1016/S1474-4422(18)30403-4 ID - Nichols2019 ER - TY - STD TI - Association A. 2018 Alzheimer’s disease facts and figures. Alzheimer’s Dement. Elsevier; 2018; 14(3):367–429 [cited 2018 Jun 18]. Available from: https://www.sciencedirect.com/science/article/pii/S1552526018300414. UR - https://www.sciencedirect.com/science/article/pii/S1552526018300414 ID - ref2 ER - TY - JOUR AU - Persson, C. M. AU - Wallin, A. K. AU - Levander, S. AU - Minthon, L. PY - 2009 DA - 2009// TI - Changes in cognitive domains during three years in patients with Alzheimer’s disease treated with donepezil JO - BMC Neurol VL - 9 UR - https://doi.org/10.1186/1471-2377-9-7 DO - 10.1186/1471-2377-9-7 ID - Persson2009 ER - TY - JOUR AU - Ito, K. AU - Ahadieh, S. AU - Corrigan, B. AU - French, J. AU - Fullerton, T. AU - Tensfeldt, T. PY - 2010 DA - 2010// TI - Disease progression meta-analysis model in Alzheimer’s disease JO - Alzheimers Dement VL - 6 UR - https://doi.org/10.1016/j.jalz.2009.05.665 DO - 10.1016/j.jalz.2009.05.665 ID - Ito2010 ER - TY - JOUR AU - Kandimalla, R. AU - Reddy, P. H. PY - 2017 DA - 2017// TI - Therapeutics of neurotransmitters in Alzheimer’s disease JO - J Alzheimers Dis VL - 57 UR - https://doi.org/10.3233/JAD-161118 DO - 10.3233/JAD-161118 ID - Kandimalla2017 ER - TY - JOUR AU - Knopman, D. S. PY - 2019 DA - 2019// TI - Lowering of amyloid-beta by β-secretase inhibitors - some informative failures JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMe1903193 DO - 10.1056/NEJMe1903193 ID - Knopman2019 ER - TY - JOUR AU - Dyck, C. H. PY - 2018 DA - 2018// TI - Anti-amyloid-β monoclonal antibodies for Alzheimer’s disease: pitfalls and promise JO - Biol Psychiatry VL - 83 UR - https://doi.org/10.1016/j.biopsych.2017.08.010 DO - 10.1016/j.biopsych.2017.08.010 ID - Dyck2018 ER - TY - JOUR AU - Viola, K. L. AU - Klein, W. L. PY - 2015 DA - 2015// TI - Amyloid beta oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis JO - Acta Neuropathol VL - 129 UR - https://doi.org/10.1007/s00401-015-1386-3 DO - 10.1007/s00401-015-1386-3 ID - Viola2015 ER - TY - BOOK AU - Cajal, S. R. PY - 1995 DA - 1995// TI - Histology of the nervous system of man and vertebrates, volume 1 PB - Oxford University Press CY - New York ID - Cajal1995 ER - TY - BOOK AU - Hebb, D. PY - 1949 DA - 1949// TI - The organization of behavior: a neuropsychological theory [Internet] PB - Wiley CY - New York ID - Hebb1949 ER - TY - JOUR AU - Kandel, E. R. PY - 2001 DA - 2001// TI - The molecular biology of memory storage: a dialogue between genes and synapses JO - Science VL - 294 UR - https://doi.org/10.1126/science.1067020 DO - 10.1126/science.1067020 ID - Kandel2001 ER - TY - JOUR AU - Bliss, T. V. AU - Lomo, T. PY - 1973 DA - 1973// TI - Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path JO - J Physiol VL - 232 UR - https://doi.org/10.1113/jphysiol.1973.sp010273 DO - 10.1113/jphysiol.1973.sp010273 ID - Bliss1973 ER - TY - JOUR AU - Takeuchi, T. AU - Duszkiewicz, A. J. AU - RGM, M. PY - 2014 DA - 2014// TI - The synaptic plasticity and memory hypothesis: encoding, storage and persistence JO - Philos Trans R Soc Lond B Biol Sci VL - 369 UR - https://doi.org/10.1098/rstb.2013.0288 DO - 10.1098/rstb.2013.0288 ID - Takeuchi2014 ER - TY - JOUR AU - Wilde, M. C. AU - Overk, C. R. AU - Sijben, J. W. AU - Masliah, E. PY - 2016 DA - 2016// TI - Meta-analysis of synaptic pathology in Alzheimer’s disease reveals selective molecular vesicular machinery vulnerability JO - Alzheimer’s Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2015.12.005 DO - 10.1016/j.jalz.2015.12.005 ID - Wilde2016 ER - TY - JOUR AU - Spires-Jones, T. L. AU - Hyman, B. PY - 2014 DA - 2014// TI - The intersection of amyloid beta and tau at synapses in Alzheimer’s disease JO - Neuron VL - 82 UR - https://doi.org/10.1016/j.neuron.2014.05.004 DO - 10.1016/j.neuron.2014.05.004 ID - Spires-Jones2014 ER - TY - JOUR AU - DeKosky, S. T. AU - Scheff, S. W. PY - 1990 DA - 1990// TI - Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity JO - Ann Neurol VL - 27 UR - https://doi.org/10.1002/ana.410270502 DO - 10.1002/ana.410270502 ID - DeKosky1990 ER - TY - JOUR AU - Blennow, K. AU - Bogdanovic, N. AU - Alafuzoff, I. AU - Ekman, R. AU - Davidsson, P. PY - 1996 DA - 1996// TI - Synaptic pathology in Alzheimer’s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele JO - J Neural Transm VL - 103 UR - https://doi.org/10.1007/BF01273157 DO - 10.1007/BF01273157 ID - Blennow1996 ER - TY - JOUR AU - DeKosky, S. T. AU - Scheff, S. W. AU - Styren, S. D. PY - 1996 DA - 1996// TI - Structural correlates of cognition in dementia: quantification and assessment of synapse change JO - Neurodegeneration VL - 5 UR - https://doi.org/10.1006/neur.1996.0056 DO - 10.1006/neur.1996.0056 ID - DeKosky1996 ER - TY - JOUR AU - Terry, R. D. AU - Masliah, E. AU - Salmon, D. P. AU - Butters, N. AU - DeTeresa, R. AU - Hill, R. PY - 1991 DA - 1991// TI - Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment JO - Ann Neurol VL - 30 UR - https://doi.org/10.1002/ana.410300410 DO - 10.1002/ana.410300410 ID - Terry1991 ER - TY - JOUR AU - Scheff, S. W. AU - Price, D. A. PY - 2003 DA - 2003// TI - Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies JO - Neurobiol Aging VL - 24 UR - https://doi.org/10.1016/j.neurobiolaging.2003.08.002 DO - 10.1016/j.neurobiolaging.2003.08.002 ID - Scheff2003 ER - TY - JOUR AU - Scheff, S. W. AU - Price, D. A. AU - Ansari, M. A. AU - Roberts, K. N. AU - Schmitt, F. A. AU - Ikonomovic, M. D. PY - 2015 DA - 2015// TI - Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer’s disease JO - J Alzheimers Dis VL - 43 UR - https://doi.org/10.3233/JAD-141518 DO - 10.3233/JAD-141518 ID - Scheff2015 ER - TY - JOUR AU - Scheff, S. W. AU - Price, D. A. AU - Schmitt, F. A. AU - Roberts, K. N. AU - Ikonomovic, M. D. AU - Mufson, E. J. PY - 2013 DA - 2013// TI - Synapse stability in the precuneus early in the progression of Alzheimer’s disease JO - J Alzheimers Dis VL - 35 UR - https://doi.org/10.3233/JAD-122353 DO - 10.3233/JAD-122353 ID - Scheff2013 ER - TY - JOUR AU - Kashani, A. AU - Lepicard, E. AU - Poirel, O. AU - Videau, C. AU - David, J. P. AU - Fallet-Bianco, C. PY - 2008 DA - 2008// TI - Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease JO - Neurobiol Aging VL - 29 UR - https://doi.org/10.1016/j.neurobiolaging.2007.04.010 DO - 10.1016/j.neurobiolaging.2007.04.010 ID - Kashani2008 ER - TY - JOUR AU - Bereczki, E. AU - Branca, R. M. AU - Francis, P. T. AU - Pereira, J. B. AU - Baek, J. -. H. AU - Hortobágyi, T. PY - 2018 DA - 2018// TI - Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach JO - Brain VL - 141 UR - https://doi.org/10.1093/brain/awx352 DO - 10.1093/brain/awx352 ID - Bereczki2018 ER - TY - JOUR AU - Bereczki, E. AU - Francis, P. T. AU - Howlett, D. AU - Pereira, J. B. AU - Höglund, K. AU - Bogstedt, A. PY - 2016 DA - 2016// TI - Synaptic proteins predict cognitive decline in Alzheimer’s disease and Lewy body dementia JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2016.04.005 DO - 10.1016/j.jalz.2016.04.005 ID - Bereczki2016 ER - TY - JOUR AU - Whitfield, D. R. AU - Vallortigara, J. AU - Alghamdi, A. AU - Howlett, D. AU - Hortobágyi, T. AU - Johnson, M. PY - 2014 DA - 2014// TI - Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer’s disease: association with cognitive impairment JO - Neurobiol Aging VL - 35 UR - https://doi.org/10.1016/j.neurobiolaging.2014.06.015 DO - 10.1016/j.neurobiolaging.2014.06.015 ID - Whitfield2014 ER - TY - JOUR AU - Scheltens, P. AU - Blennow, K. AU - Breteler, M. M. B. AU - Strooper, B. AU - Frisoni, G. B. AU - Salloway, S. PY - 2016 DA - 2016// TI - Alzheimer’s disease JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(15)01124-1 DO - 10.1016/S0140-6736(15)01124-1 ID - Scheltens2016 ER - TY - JOUR AU - Serrano-Pozo, A. AU - Frosch, M. P. AU - Masliah, E. AU - Hyman, B. T. PY - 2011 DA - 2011// TI - Neuropathological alterations in Alzheimer disease JO - Cold Spring Harb Perspect Med VL - 1 UR - https://doi.org/10.1101/cshperspect.a006189 DO - 10.1101/cshperspect.a006189 ID - Serrano-Pozo2011 ER - TY - JOUR AU - Hyman, B. T. AU - Phelps, C. H. AU - Beach, T. G. AU - Bigio, E. H. AU - Cairns, N. J. AU - Carrillo, M. C. PY - 2012 DA - 2012// TI - National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease JO - Alzheimers Dement VL - 8 UR - https://doi.org/10.1016/j.jalz.2011.10.007 DO - 10.1016/j.jalz.2011.10.007 ID - Hyman2012 ER - TY - JOUR AU - Koffie, R. M. AU - Hashimoto, T. AU - Tai, H. -. C. AU - Kay, K. R. AU - Serrano-Pozo, A. AU - Joyner, D. PY - 2012 DA - 2012// TI - Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β JO - Brain VL - 135 UR - https://doi.org/10.1093/brain/aws127 DO - 10.1093/brain/aws127 ID - Koffie2012 ER - TY - JOUR AU - Koffie, R. M. AU - Meyer-Luehmann, M. AU - Hashimoto, T. AU - Adams, K. W. AU - Mielke, M. L. AU - Garcia-Alloza, M. PY - 2009 DA - 2009// TI - Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0811698106 DO - 10.1073/pnas.0811698106 ID - Koffie2009 ER - TY - JOUR AU - Spires, T. L. AU - Meyer-Luehmann, M. AU - Stern, E. A. AU - McLean, P. J. AU - Skoch, J. AU - Nguyen, P. T. PY - 2005 DA - 2005// TI - Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy JO - J Neurosci VL - 25 UR - https://doi.org/10.1523/JNEUROSCI.1879-05.2005 DO - 10.1523/JNEUROSCI.1879-05.2005 ID - Spires2005 ER - TY - JOUR AU - Jackson, R. J. AU - Rudinskiy, N. AU - Herrmann, A. G. AU - Croft, S. AU - Kim, J. M. AU - Petrova, V. PY - 2016 DA - 2016// TI - Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer’s disease JO - Eur J Neurosci VL - 44 UR - https://doi.org/10.1111/ejn.13442 DO - 10.1111/ejn.13442 ID - Jackson2016 ER - TY - JOUR AU - Yu, Y. AU - Jans, D. C. AU - Winblad, B. AU - Tjernberg, L. O. AU - Schedin-Weiss, S. PY - 2018 DA - 2018// TI - Neuronal Aβ42 is enriched in small vesicles at the presynaptic side of synapses JO - Life Sci Alliance VL - 1 UR - https://doi.org/10.26508/lsa.201800028 DO - 10.26508/lsa.201800028 ID - Yu2018 ER - TY - JOUR AU - Ashe, K. H. AU - Zahs, K. R. PY - 2010 DA - 2010// TI - Probing the biology of Alzheimer’s disease in mice JO - Neuron VL - 66 UR - https://doi.org/10.1016/j.neuron.2010.04.031 DO - 10.1016/j.neuron.2010.04.031 ID - Ashe2010 ER - TY - JOUR AU - Sasaguri, H. AU - Nilsson, P. AU - Hashimoto, S. AU - Nagata, K. AU - Saito, T. AU - Strooper, B. PY - 2017 DA - 2017// TI - APP mouse models for Alzheimer’s disease preclinical studies JO - EMBO J VL - 36 UR - https://doi.org/10.15252/embj.201797397 DO - 10.15252/embj.201797397 ID - Sasaguri2017 ER - TY - JOUR AU - Saito, T. AU - Matsuba, Y. AU - Mihira, N. AU - Takano, J. AU - Nilsson, P. AU - Itohara, S. PY - 2014 DA - 2014// TI - Single App knock-in mouse models of Alzheimer’s disease JO - Nat Neurosci VL - 17 UR - https://doi.org/10.1038/nn.3697 DO - 10.1038/nn.3697 ID - Saito2014 ER - TY - JOUR AU - Nelson, P. T. AU - Alafuzoff, I. AU - Bigio, E. H. AU - Bouras, C. AU - Braak, H. AU - Cairns, N. J. PY - 2012 DA - 2012// TI - Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature JO - J Neuropathol Exp Neurol VL - 71 UR - https://doi.org/10.1097/NEN.0b013e31825018f7 DO - 10.1097/NEN.0b013e31825018f7 ID - Nelson2012 ER - TY - JOUR AU - Masliah, E. AU - Hansen, L. AU - Albright, T. AU - Mallory, M. AU - Terry, R. D. PY - 1991 DA - 1991// TI - Immunoelectron microscopic study of synaptic pathology in Alzheimer’s disease JO - Acta Neuropathol VL - 81 UR - https://doi.org/10.1007/BF00293464 DO - 10.1007/BF00293464 ID - Masliah1991 ER - TY - STD TI - Cline EN, Bicca MA, Viola KL, Klein WL. The amyloid-β oligomer hypothesis: beginning of the third decade. J Alzheimers Dis. 2018;64:S567–610. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29843241. UR - http://www.ncbi.nlm.nih.gov/pubmed/29843241 ID - ref40 ER - TY - JOUR AU - Lambert, M. P. AU - Barlow, A. K. AU - Chromy, B. A. AU - Edwards, C. AU - Freed, R. AU - Liosatos, M. PY - 1998 DA - 1998// TI - Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.11.6448 DO - 10.1073/pnas.95.11.6448 ID - Lambert1998 ER - TY - JOUR AU - Walsh, D. M. AU - Klyubin, I. AU - Fadeeva, J. V. AU - Cullen, W. K. AU - Anwyl, R. AU - Wolfe, M. S. PY - 2002 DA - 2002// TI - Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo JO - Nature VL - 416 UR - https://doi.org/10.1038/416535a DO - 10.1038/416535a ID - Walsh2002 ER - TY - JOUR AU - Cleary, J. P. AU - Walsh, D. M. AU - Hofmeister, J. J. AU - Shankar, G. M. AU - Kuskowski, M. A. AU - Selkoe, D. J. PY - 2005 DA - 2005// TI - Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function JO - Nat Neurosci VL - 8 UR - https://doi.org/10.1038/nn1372 DO - 10.1038/nn1372 ID - Cleary2005 ER - TY - JOUR AU - Lesné, S. AU - Koh, M. T. AU - Kotilinek, L. AU - Kayed, R. AU - Glabe, C. G. AU - Yang, A. PY - 2006 DA - 2006// TI - A specific amyloid-beta protein assembly in the brain impairs memory JO - Nature VL - 440 UR - https://doi.org/10.1038/nature04533 DO - 10.1038/nature04533 ID - Lesné2006 ER - TY - JOUR AU - Shankar, G. M. AU - Li, S. AU - Mehta, T. H. AU - Garcia-Munoz, A. AU - Shepardson, N. E. AU - Smith, I. PY - 2008 DA - 2008// TI - Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm1782 DO - 10.1038/nm1782 ID - Shankar2008 ER - TY - JOUR AU - Lesné, S. E. AU - Sherman, M. A. AU - Grant, M. AU - Kuskowski, M. AU - Schneider, J. A. AU - Bennett, D. A. PY - 2013 DA - 2013// TI - Brain amyloid-β oligomers in ageing and Alzheimer’s disease JO - Brain VL - 136 UR - https://doi.org/10.1093/brain/awt062 DO - 10.1093/brain/awt062 ID - Lesné2013 ER - TY - JOUR AU - Esparza, T. J. AU - Zhao, H. AU - Cirrito, J. R. AU - Cairns, N. J. AU - Bateman, R. J. AU - Holtzman, D. M. PY - 2013 DA - 2013// TI - Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls JO - Ann Neurol VL - 73 UR - https://doi.org/10.1002/ana.23748 DO - 10.1002/ana.23748 ID - Esparza2013 ER - TY - JOUR AU - Perez-Nievas, B. G. AU - Stein, T. D. AU - Tai, H. -. C. AU - Dols-Icardo, O. AU - Scotton, T. C. AU - Barroeta-Espar, I. PY - 2013 DA - 2013// TI - Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology JO - Brain VL - 136 UR - https://doi.org/10.1093/brain/awt171 DO - 10.1093/brain/awt171 ID - Perez-Nievas2013 ER - TY - JOUR AU - Lacor, P. N. AU - Buniel, M. C. AU - Furlow, P. W. AU - Clemente, A. S. AU - Velasco, P. T. AU - Wood, M. PY - 2007 DA - 2007// TI - Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease JO - J Neurosci VL - 27 UR - https://doi.org/10.1523/JNEUROSCI.3501-06.2007 DO - 10.1523/JNEUROSCI.3501-06.2007 ID - Lacor2007 ER - TY - JOUR AU - Wang, Z. AU - Jackson, R. J. AU - Hong, W. AU - Taylor, W. M. AU - Corbett, G. T. AU - Moreno, A. PY - 2017 DA - 2017// TI - Human brain-derived Aβ oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP JO - J Neurosci VL - 37 UR - https://doi.org/10.1523/JNEUROSCI.2009-17.2017 DO - 10.1523/JNEUROSCI.2009-17.2017 ID - Wang2017 ER - TY - JOUR AU - Calabrese, B. AU - Shaked, G. M. AU - Tabarean, I. V. AU - Braga, J. AU - Koo, E. H. AU - Halpain, S. PY - 2007 DA - 2007// TI - Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein JO - Mol Cell Neurosci VL - 35 UR - https://doi.org/10.1016/j.mcn.2007.02.006 DO - 10.1016/j.mcn.2007.02.006 ID - Calabrese2007 ER - TY - JOUR AU - Lue, L. -. F. AU - Kuo, Y. -. M. AU - Roher, A. E. AU - Brachova, L. AU - Shen, Y. AU - Sue, L. PY - 1999 DA - 1999// TI - Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer’s disease JO - Am J Pathol VL - 155 UR - https://doi.org/10.1016/S0002-9440(10)65184-X DO - 10.1016/S0002-9440(10)65184-X ID - Lue1999 ER - TY - JOUR AU - Bao, F. AU - Wicklund, L. AU - Lacor, P. N. AU - Klein, W. L. AU - Nordberg, A. AU - Marutle, A. PY - 2012 DA - 2012// TI - Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity JO - Neurobiol Aging VL - 33 UR - https://doi.org/10.1016/j.neurobiolaging.2011.05.003 DO - 10.1016/j.neurobiolaging.2011.05.003 ID - Bao2012 ER - TY - JOUR AU - Pickett, E. K. AU - Koffie, R. M. AU - Wegmann, S. AU - Henstridge, C. M. AU - Herrmann, A. G. AU - Colom-Cadena, M. PY - 2016 DA - 2016// TI - Non-fibrillar oligomeric amyloid-β within synapses JO - J Alzheimers Dis VL - 53 UR - https://doi.org/10.3233/JAD-160007 DO - 10.3233/JAD-160007 ID - Pickett2016 ER - TY - JOUR AU - Benilova, I. AU - Strooper, B. PY - 2013 DA - 2013// TI - Neuroscience. Promiscuous Alzheimer’s amyloid: yet another partner JO - Science VL - 341 UR - https://doi.org/10.1126/science.1244166 DO - 10.1126/science.1244166 ID - Benilova2013 ER - TY - JOUR AU - Haas, L. T. AU - Salazar, S. V. AU - Kostylev, M. A. AU - Um, J. W. AU - Kaufman, A. C. AU - Strittmatter, S. M. PY - 2016 DA - 2016// TI - Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer’s disease JO - Brain VL - 139 UR - https://doi.org/10.1093/brain/awv356 DO - 10.1093/brain/awv356 ID - Haas2016 ER - TY - JOUR AU - Alon, A. AU - Schmidt, H. R. AU - Wood, M. D. AU - Sahn, J. J. AU - Martin, S. F. AU - Kruse, A. C. PY - 2017 DA - 2017// TI - Identification of the gene that codes for the σ 2 receptor JO - Proc Natl Acad Sci VL - 114 UR - https://doi.org/10.1073/pnas.1705154114 DO - 10.1073/pnas.1705154114 ID - Alon2017 ER - TY - JOUR AU - Xu, J. AU - Zeng, C. AU - Chu, W. AU - Pan, F. AU - Rothfuss, J. M. AU - Zhang, F. PY - 2011 DA - 2011// TI - Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site JO - Nat Commun VL - 2 UR - https://doi.org/10.1038/ncomms1386 DO - 10.1038/ncomms1386 ID - Xu2011 ER - TY - JOUR AU - Riad, A. AU - Zeng, C. AU - Weng, C. -. C. AU - Winters, H. AU - Xu, K. AU - Makvandi, M. PY - 2018 DA - 2018// TI - Sigma-2 receptor/TMEM97 and PGRMC-1 increase the rate of internalization of LDL by LDL receptor through the formation of a ternary complex JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-35430-3 DO - 10.1038/s41598-018-35430-3 ID - Riad2018 ER - TY - JOUR AU - Smith, L. M. AU - Strittmatter, S. M. PY - 2017 DA - 2017// TI - Binding sites for amyloid-β oligomers and synaptic toxicity JO - Cold Spring Harb Perspect Med VL - 7 UR - https://doi.org/10.1101/cshperspect.a024075 DO - 10.1101/cshperspect.a024075 ID - Smith2017 ER - TY - JOUR AU - Cissé, M. AU - Halabisky, B. AU - Harris, J. AU - Devidze, N. AU - Dubal, D. B. AU - Sun, B. PY - 2011 DA - 2011// TI - Reversing EphB2 depletion rescues cognitive functions in Alzheimer model JO - Nature VL - 469 UR - https://doi.org/10.1038/nature09635 DO - 10.1038/nature09635 ID - Cissé2011 ER - TY - JOUR AU - Izzo, N. J. AU - Staniszewski, A. AU - Fa, M. AU - Teich, A. F. AU - Saeed, F. PY - 2014 DA - 2014// TI - Alzheimer’s therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0111898 DO - 10.1371/journal.pone.0111898 ID - Izzo2014 ER - TY - JOUR AU - Izzo, N. J. AU - Xu, J. AU - Zeng, C. AU - Kirk, M. J. AU - Mozzoni, K. AU - Silky, C. PY - 2014 DA - 2014// TI - Alzheimer’s therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0111899 DO - 10.1371/journal.pone.0111899 ID - Izzo2014 ER - TY - JOUR AU - Grundman, M. AU - Morgan, R. AU - Lickliter, J. D. AU - Schneider, L. S. AU - DeKosky, S. AU - Izzo, N. J. PY - 2019 DA - 2019// TI - A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer’s disease JO - Alzheimer’s Dement (New York, N Y) VL - 5 ID - Grundman2019 ER - TY - JOUR AU - Kuchibhotla, K. V. AU - Lattarulo, C. R. AU - Hyman, B. T. AU - Bacskai, B. J. PY - 2009 DA - 2009// TI - Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice JO - Science VL - 323 UR - https://doi.org/10.1126/science.1169096 DO - 10.1126/science.1169096 ID - Kuchibhotla2009 ER - TY - JOUR AU - Busche, M. A. AU - Eichhoff, G. AU - Adelsberger, H. AU - Abramowski, D. AU - Wiederhold, K. -. H. AU - Haass, C. PY - 2008 DA - 2008// TI - Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease JO - Science VL - 321 UR - https://doi.org/10.1126/science.1162844 DO - 10.1126/science.1162844 ID - Busche2008 ER - TY - JOUR AU - Gomez-Isla, T. PY - 1997 DA - 1997// TI - Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease JO - Ann Neurol VL - 41 UR - https://doi.org/10.1002/ana.410410106 DO - 10.1002/ana.410410106 ID - Gomez-Isla1997 ER - TY - JOUR AU - Spires, T. L. AU - Orne, J. D. AU - SantaCruz, K. AU - Pitstick, R. AU - Carlson, G. A. AU - Ashe, K. H. PY - 2006 DA - 2006// TI - Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy JO - Am J Pathol VL - 168 UR - https://doi.org/10.2353/ajpath.2006.050840 DO - 10.2353/ajpath.2006.050840 ID - Spires2006 ER - TY - JOUR AU - Santa Cruz, K. PY - 2005 DA - 2005// TI - Tau suppression in a neurodegenerative mouse model improves memory function JO - Science VL - 309 UR - https://doi.org/10.1126/science.1113694 DO - 10.1126/science.1113694 ID - Santa Cruz2005 ER - TY - JOUR AU - Polydoro, M. AU - Acker, C. M. AU - Duff, K. AU - Castillo, P. E. AU - Davies, P. PY - 2009 DA - 2009// TI - Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology JO - J Neurosci VL - 29 UR - https://doi.org/10.1523/JNEUROSCI.1065-09.2009 DO - 10.1523/JNEUROSCI.1065-09.2009 ID - Polydoro2009 ER - TY - JOUR AU - Allen, B. AU - Ingram, E. AU - Takao, M. AU - Smith, M. J. AU - Jakes, R. AU - Virdee, K. PY - 2002 DA - 2002// TI - Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein JO - J Neurosci VL - 22 UR - https://doi.org/10.1523/JNEUROSCI.22-21-09340.2002 DO - 10.1523/JNEUROSCI.22-21-09340.2002 ID - Allen2002 ER - TY - JOUR AU - Busche, M. A. PY - 2018 DA - 2018// TI - In vivo two-photon calcium imaging of hippocampal neurons in Alzheimer mouse models JO - Methods Mol Biol VL - 1750 UR - https://doi.org/10.1007/978-1-4939-7704-8_23 DO - 10.1007/978-1-4939-7704-8_23 ID - Busche2018 ER - TY - JOUR AU - Fu, H. AU - Possenti, A. AU - Freer, R. AU - Nakano, Y. AU - Villegas, N. C. H. AU - Tang, M. PY - 2019 DA - 2019// TI - A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology JO - Nat Neurosci VL - 22 UR - https://doi.org/10.1038/s41593-018-0298-7 DO - 10.1038/s41593-018-0298-7 ID - Fu2019 ER - TY - JOUR AU - Menkes-Caspi, N. AU - Yamin, H. G. AU - Kellner, V. AU - Spires-Jones, T. L. AU - Cohen, D. AU - Stern, E. A. PY - 2015 DA - 2015// TI - Pathological tau disrupts ongoing network activity JO - Neuron VL - 85 UR - https://doi.org/10.1016/j.neuron.2015.01.025 DO - 10.1016/j.neuron.2015.01.025 ID - Menkes-Caspi2015 ER - TY - JOUR AU - Crimins, J. L. AU - Rocher, A. B. AU - Peters, A. AU - Shultz, P. AU - Lewis, J. AU - Luebke, J. I. PY - 2011 DA - 2011// TI - Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy JO - Acta Neuropathol VL - 122 UR - https://doi.org/10.1007/s00401-011-0877-0 DO - 10.1007/s00401-011-0877-0 ID - Crimins2011 ER - TY - JOUR AU - Rocher, A. B. AU - Crimins, J. L. AU - Amatrudo, J. M. AU - Kinson, M. S. AU - Todd-Brown, M. A. AU - Lewis, J. PY - 2010 DA - 2010// TI - Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs JO - Exp Neurol [Internet] VL - 223 UR - https://doi.org/10.1016/j.expneurol.2009.07.029 DO - 10.1016/j.expneurol.2009.07.029 ID - Rocher2010 ER - TY - JOUR AU - Yoshiyama, Y. AU - Higuchi, M. AU - Zhang, B. AU - Huang, S. M. AU - Iwata, N. AU - Saido, T. C. C. PY - 2007 DA - 2007// TI - Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model JO - Neuron. VL - 53 UR - https://doi.org/10.1016/j.neuron.2007.01.010 DO - 10.1016/j.neuron.2007.01.010 ID - Yoshiyama2007 ER - TY - JOUR AU - Sealey, M. A. AU - Vourkou, E. AU - Cowan, C. M. AU - Bossing, T. AU - Quraishe, S. AU - Grammenoudi, S. PY - 2017 DA - 2017// TI - Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy JO - Neurobiol Dis VL - 105 UR - https://doi.org/10.1016/j.nbd.2017.05.003 DO - 10.1016/j.nbd.2017.05.003 ID - Sealey2017 ER - TY - JOUR AU - Ghag, G. AU - Bhatt, N. AU - Cantu, D. V. AU - Guerrero-Munoz, M. J. AU - Ellsworth, A. AU - Sengupta, U. PY - 2018 DA - 2018// TI - Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior JO - Protein Sci VL - 27 UR - https://doi.org/10.1002/pro.3499 DO - 10.1002/pro.3499 ID - Ghag2018 ER - TY - JOUR AU - Kopeikina, K. J. AU - Hyman, B. T. AU - Spires-Jones, T. L. PY - 2012 DA - 2012// TI - Soluble forms of tau are toxic in Alzheimer’s disease JO - Transl Neurosci VL - 3 UR - https://doi.org/10.2478/s13380-012-0032-y DO - 10.2478/s13380-012-0032-y ID - Kopeikina2012 ER - TY - JOUR AU - Kopeikina, K. J. AU - Carlson, G. A. AU - Pitstick, R. AU - Ludvigson, A. E. AU - Peters, A. AU - Luebke, J. I. PY - 2011 DA - 2011// TI - Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer’s disease brain JO - Am J Pathol VL - 179 UR - https://doi.org/10.1016/j.ajpath.2011.07.004 DO - 10.1016/j.ajpath.2011.07.004 ID - Kopeikina2011 ER - TY - JOUR AU - Pickett, E. K. AU - Rose, J. AU - McCrory, C. AU - McKenzie, C. A. AU - King, D. AU - Smith, C. PY - 2018 DA - 2018// TI - Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease JO - Acta Neuropathol VL - 136 UR - https://doi.org/10.1007/s00401-018-1903-2 DO - 10.1007/s00401-018-1903-2 ID - Pickett2018 ER - TY - JOUR AU - Ittner, A. AU - Ittner, L. M. PY - 2018 DA - 2018// TI - Dendritic tau in Alzheimer’s disease JO - Neuron VL - 99 UR - https://doi.org/10.1016/j.neuron.2018.06.003 DO - 10.1016/j.neuron.2018.06.003 ID - Ittner2018 ER - TY - JOUR AU - McInnes, J. AU - Wierda, K. AU - Snellinx, A. AU - Bounti, L. AU - Wang, Y. C. AU - Stancu, I. C. PY - 2018 DA - 2018// TI - Synaptogyrin-3 mediates presynaptic dysfunction induced by tau JO - Neuron VL - 97 UR - https://doi.org/10.1016/j.neuron.2018.01.022 DO - 10.1016/j.neuron.2018.01.022 ID - McInnes2018 ER - TY - JOUR AU - Zhou, L. AU - McInnes, J. AU - Wierda, K. AU - Holt, M. AU - Herrmann, A. G. AU - Jackson, R. J. PY - 2017 DA - 2017// TI - Tau association with synaptic vesicles causes presynaptic dysfunction JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms15295 DO - 10.1038/ncomms15295 ID - Zhou2017 ER - TY - JOUR AU - Tai, H. AU - Serrano-Pozo, A. AU - Hashimoto, T. AU - Frosch, M. P. AU - Spires-Jones, T. L. AU - Hyman, B. T. PY - 2012 DA - 2012// TI - The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system JO - Am J Pathol VL - 181 UR - https://doi.org/10.1016/j.ajpath.2012.06.033 DO - 10.1016/j.ajpath.2012.06.033 ID - Tai2012 ER - TY - JOUR AU - Tai, H. C. AU - Wang, B. Y. AU - Serrano-Pozo, A. AU - Frosch, M. P. AU - Spires-Jones, T. L. AU - Hyman, B. T. PY - 2014 DA - 2014// TI - Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease JO - Acta Neuropathol Commun VL - 2 UR - https://doi.org/10.1186/2051-5960-2-1 DO - 10.1186/2051-5960-2-1 ID - Tai2014 ER - TY - STD TI - Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27025652. UR - http://www.ncbi.nlm.nih.gov/pubmed/27025652 ID - ref88 ER - TY - JOUR AU - Ittner, L. M. AU - Ke, Y. D. AU - Delerue, F. AU - Bi, M. AU - Gladbach, A. AU - Eersel, J. PY - 2010 DA - 2010// TI - Dendritic function of tau mediates amyloid-β toxicity in Alzheimer’s disease mouse models JO - Cell VL - 142 UR - https://doi.org/10.1016/j.cell.2010.06.036 DO - 10.1016/j.cell.2010.06.036 ID - Ittner2010 ER - TY - JOUR AU - Roberson, E. D. AU - Halabisky, B. AU - Yoo, J. W. AU - Yao, J. AU - Chin, J. AU - Yan, F. PY - 2011 DA - 2011// TI - Amyloid-/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease JO - J Neurosci VL - 31 UR - https://doi.org/10.1523/JNEUROSCI.4152-10.2011 DO - 10.1523/JNEUROSCI.4152-10.2011 ID - Roberson2011 ER - TY - JOUR AU - Roberson, E. D. AU - Scearce-Levie, K. AU - Palop, J. J. AU - Yan, F. AU - Cheng, I. H. AU - Wu, T. PY - 2007 DA - 2007// TI - Reducing endogenous tau ameliorates amyloid -induced deficits in an Alzheimer’s disease mouse model JO - Science VL - 316 UR - https://doi.org/10.1126/science.1141736 DO - 10.1126/science.1141736 ID - Roberson2007 ER - TY - JOUR AU - Shipton, O. A. AU - Leitz, J. R. AU - Dworzak, J. AU - Acton, C. E. J. AU - Tunbridge, E. M. AU - Denk, F. PY - 2011 DA - 2011// TI - Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation JO - J Neurosci VL - 31 UR - https://doi.org/10.1523/JNEUROSCI.2610-10.2011 DO - 10.1523/JNEUROSCI.2610-10.2011 ID - Shipton2011 ER - TY - JOUR AU - Henstridge, C. M. AU - Hyman, B. T. AU - Spires-Jones, T. L. PY - 2019 DA - 2019// TI - Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis JO - Nat Rev Neurosci VL - 20 UR - https://doi.org/10.1038/s41583-018-0113-1 DO - 10.1038/s41583-018-0113-1 ID - Henstridge2019 ER - TY - JOUR AU - Corder, E. H. AU - Saunders, A. M. AU - Strittmatter, W. J. AU - Schmechel, D. E. AU - Gaskell, P. C. AU - Small, G. W. PY - 1993 DA - 1993// TI - Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families JO - Science VL - 261 UR - https://doi.org/10.1126/science.8346443 DO - 10.1126/science.8346443 ID - Corder1993 ER - TY - JOUR AU - Keren-Shaul, H. AU - Spinrad, A. AU - Weiner, A. AU - Matcovitch-Natan, O. AU - Dvir-Szternfeld, R. AU - Ulland, T. K. PY - 2017 DA - 2017// TI - A unique microglia type associated with restricting development of Alzheimer’s disease JO - Cell VL - 169 UR - https://doi.org/10.1016/j.cell.2017.05.018 DO - 10.1016/j.cell.2017.05.018 ID - Keren-Shaul2017 ER - TY - JOUR AU - Hudry, E. AU - Dashkoff, J. AU - Roe, A. D. AU - Takeda, S. AU - Koffie, R. M. AU - Hashimoto, T. PY - 2013 DA - 2013// TI - Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3007000 DO - 10.1126/scitranslmed.3007000 ID - Hudry2013 ER - TY - JOUR AU - Hudry, E. AU - Klickstein, J. AU - Cannavo, C. AU - Jackson, R. AU - Muzikansky, A. AU - Gandhi, S. PY - 2019 DA - 2019// TI - Opposing roles of apolipoprotein E in aging and neurodegeneration JO - Life Sci Alliance VL - 2 UR - https://doi.org/10.26508/lsa.201900325 DO - 10.26508/lsa.201900325 ID - Hudry2019 ER - TY - JOUR AU - Hong, S. AU - Beja-Glasser, V. F. AU - Nfonoyim, B. M. AU - Frouin, A. AU - Li, S. AU - Ramakrishnan, S. PY - 2016 DA - 2016// TI - Complement and microglia mediate early synapse loss in Alzheimer mouse models JO - Science VL - 8373 ID - Hong2016 ER - TY - STD TI - Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci Transl Med. 2017;9(392):eaaf6295. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28566429. UR - http://www.ncbi.nlm.nih.gov/pubmed/28566429 ID - ref99 ER - TY - JOUR AU - Davies, C. AU - Spires-Jones, T. L. PY - 2018 DA - 2018// TI - Complementing tau: new data show that the complement system is involved in degeneration in tauopathies JO - Neuron VL - 100 UR - https://doi.org/10.1016/j.neuron.2018.12.003 DO - 10.1016/j.neuron.2018.12.003 ID - Davies2018 ER - TY - JOUR AU - Litvinchuk, A. AU - Wan, Y. -. W. AU - Swartzlander, D. B. AU - Chen, F. AU - Cole, A. AU - Propson, N. E. PY - 2018 DA - 2018// TI - Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer’s disease JO - Neuron VL - 100 UR - https://doi.org/10.1016/j.neuron.2018.10.031 DO - 10.1016/j.neuron.2018.10.031 ID - Litvinchuk2018 ER - TY - JOUR AU - Dejanovic, B. AU - Huntley, M. A. AU - Mazière, A. AU - Meilandt, W. J. AU - Wu, T. AU - Srinivasan, K. PY - 2018 DA - 2018// TI - Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies JO - Neuron VL - 100 UR - https://doi.org/10.1016/j.neuron.2018.10.014 DO - 10.1016/j.neuron.2018.10.014 ID - Dejanovic2018 ER - TY - JOUR AU - Spires-Jones, T. L. AU - Mielke, M. L. AU - Rozkalne, A. AU - Meyer-Luehmann, M. AU - Calignon, A. AU - Bacskai, B. J. PY - 2009 DA - 2009// TI - Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease JO - Neurobiol Dis VL - 33 UR - https://doi.org/10.1016/j.nbd.2008.10.011 DO - 10.1016/j.nbd.2008.10.011 ID - Spires-Jones2009 ER - TY - JOUR AU - Sydow, A. AU - Jeugd, A. AU - Zheng, F. AU - Ahmed, T. AU - Balschun, D. AU - Petrova, O. PY - 2011 DA - 2011// TI - Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model JO - J Mol Neurosci VL - 45 UR - https://doi.org/10.1007/s12031-011-9604-5 DO - 10.1007/s12031-011-9604-5 ID - Sydow2011 ER - TY - JOUR AU - Sydow, A. AU - Jeugd, A. AU - Zheng, F. AU - Ahmed, T. AU - Balschun, D. AU - Petrova, O. PY - 2011 DA - 2011// TI - Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant JO - J Neurosci VL - 31 UR - https://doi.org/10.1523/JNEUROSCI.5245-10.2011 DO - 10.1523/JNEUROSCI.5245-10.2011 ID - Sydow2011 ER - TY - STD TI - Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature. 2000;408(6815):979–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11140685. UR - http://www.ncbi.nlm.nih.gov/pubmed/11140685 ID - ref106 ER - TY - JOUR AU - Schenk, D. AU - Barbour, R. AU - Dunn, W. AU - Gordon, G. AU - Grajeda, H. AU - Guido, T. PY - 1999 DA - 1999// TI - Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse JO - Nature VL - 400 UR - https://doi.org/10.1038/22124 DO - 10.1038/22124 ID - Schenk1999 ER - TY - JOUR AU - Bittar, A. AU - Sengupta, U. AU - Kayed, R. PY - 2018 DA - 2018// TI - Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies JO - NPJ vaccines VL - 3 UR - https://doi.org/10.1038/s41541-018-0046-8 DO - 10.1038/s41541-018-0046-8 ID - Bittar2018 ER - TY - JOUR AU - Jack, C. R. AU - Bennett, D. A. AU - Blennow, K. AU - Carrillo, M. C. AU - Dunn, B. AU - Haeberlein, S. B. PY - 2018 DA - 2018// TI - NIA-AA research framework: toward a biological definition of Alzheimer’s disease JO - Alzheimer’s Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2018.02.018 DO - 10.1016/j.jalz.2018.02.018 ID - Jack2018 ER - TY - JOUR AU - McCleery, J. AU - Flicker, L. AU - Richard, E. AU - Quinn, T. J. PY - 2019 DA - 2019// TI - When is Alzheimer’s not dementia-Cochrane commentary on The National Institute on Ageing and Alzheimer’s Association Research Framework for Alzheimer’s Disease JO - Age Ageing VL - 48 UR - https://doi.org/10.1093/ageing/afy167 DO - 10.1093/ageing/afy167 ID - McCleery2019 ER - TY - JOUR AU - Finnema, S. J. AU - Nabulsi, N. B. AU - Eid, T. AU - Detyniecki, K. AU - Lin, S. AU - Chen, M. PY - 2016 DA - 2016// TI - Imaging synaptic density in the living human brain JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aaf6667 DO - 10.1126/scitranslmed.aaf6667 ID - Finnema2016 ER - TY - JOUR AU - Constantinescu, C. C. AU - Tresse, C. AU - Zheng, M. AU - Gouasmat, A. AU - Carroll, V. M. AU - Mistico, L. PY - 2019 DA - 2019// TI - Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers JO - Mol Imaging Biol VL - 21 UR - https://doi.org/10.1007/s11307-018-1260-5 DO - 10.1007/s11307-018-1260-5 ID - Constantinescu2019 ER - TY - JOUR AU - Li, S. AU - Cai, Z. AU - Wu, X. AU - Holden, D. AU - Pracitto, R. AU - Kapinos, M. PY - 2019 DA - 2019// TI - Synthesis and in vivo evaluation of a novel PET radiotracer for imaging of synaptic vesicle glycoprotein 2A (SV2A) in nonhuman primates JO - ACS Chem Neurosci VL - 10 UR - https://doi.org/10.1021/acschemneuro.8b00526 DO - 10.1021/acschemneuro.8b00526 ID - Li2019 ER - TY - JOUR AU - Chen, M. -. K. AU - Mecca, A. P. AU - Naganawa, M. AU - Finnema, S. J. AU - Toyonaga, T. AU - Lin, S. PY - 2018 DA - 2018// TI - Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging JO - JAMA Neurol VL - 8042 ID - Chen2018 ER - TY - JOUR AU - Davidsson, P. AU - Jahn, R. AU - Bergquist, J. AU - Ekman, R. AU - Blennow, K. PY - 1996 DA - 1996// TI - Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? JO - Mol Chem Neuropathol VL - 27 UR - https://doi.org/10.1007/BF02815094 DO - 10.1007/BF02815094 ID - Davidsson1996 ER - TY - JOUR AU - Davidsson, P. AU - Puchades, M. AU - Blennow, K. PY - 1999 DA - 1999// TI - Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing JO - Electrophoresis VL - 20 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Davidsson1999 ER - TY - JOUR AU - Kvartsberg, H. AU - Lashley, T. AU - Murray, C. E. AU - Brinkmalm, G. AU - Cullen, N. C. AU - Höglund, K. PY - 2019 DA - 2019// TI - The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease JO - Acta Neuropathol VL - 137 UR - https://doi.org/10.1007/s00401-018-1910-3 DO - 10.1007/s00401-018-1910-3 ID - Kvartsberg2019 ER - TY - JOUR AU - Thorsell, A. AU - Bjerke, M. AU - Gobom, J. AU - Brunhage, E. AU - Vanmechelen, E. AU - Andreasen, N. PY - 2010 DA - 2010// TI - Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer’s disease JO - Brain Res VL - 1362 UR - https://doi.org/10.1016/j.brainres.2010.09.073 DO - 10.1016/j.brainres.2010.09.073 ID - Thorsell2010 ER - TY - JOUR AU - Kvartsberg, H. AU - Duits, F. H. AU - Ingelsson, M. AU - Andreasen, N. AU - Öhrfelt, A. AU - Andersson, K. PY - 2015 DA - 2015// TI - Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer’s disease JO - Alzheimers Dement VL - 11 UR - https://doi.org/10.1016/j.jalz.2014.10.009 DO - 10.1016/j.jalz.2014.10.009 ID - Kvartsberg2015 ER - TY - JOUR AU - Portelius, E. AU - Zetterberg, H. AU - Skillbäck, T. AU - Törnqvist, U. AU - Andreasson, U. AU - Trojanowski, J. Q. PY - 2015 DA - 2015// TI - Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease JO - Brain VL - 138 UR - https://doi.org/10.1093/brain/awv267 DO - 10.1093/brain/awv267 ID - Portelius2015 ER - TY - JOUR AU - Tarawneh, R. AU - D’Angelo, G. AU - Crimmins, D. AU - Herries, E. AU - Griest, T. AU - Fagan, A. M. PY - 2016 DA - 2016// TI - Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease JO - JAMA Neurol VL - 73 UR - https://doi.org/10.1001/jamaneurol.2016.0086 DO - 10.1001/jamaneurol.2016.0086 ID - Tarawneh2016 ER - TY - JOUR AU - Portelius, E. AU - Olsson, B. AU - Höglund, K. AU - Cullen, N. C. AU - Kvartsberg, H. AU - Andreasson, U. PY - 2018 DA - 2018// TI - Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology JO - Acta Neuropathol VL - 136 UR - https://doi.org/10.1007/s00401-018-1851-x DO - 10.1007/s00401-018-1851-x ID - Portelius2018 ER - TY - JOUR AU - Wellington, H. AU - Paterson, R. W. AU - Portelius, E. AU - Törnqvist, U. AU - Magdalinou, N. AU - Fox, N. C. PY - 2016 DA - 2016// TI - Increased CSF neurogranin concentration is specific to Alzheimer disease JO - Neurology. VL - 86 UR - https://doi.org/10.1212/WNL.0000000000002423 DO - 10.1212/WNL.0000000000002423 ID - Wellington2016 ER - TY - JOUR AU - Sandelius, Å. AU - Portelius, E. AU - Källén, Å. AU - Zetterberg, H. AU - Rot, U. AU - Olsson, B. PY - 2019 DA - 2019// TI - Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology JO - Alzheimers Dement VL - 15 UR - https://doi.org/10.1016/j.jalz.2018.08.006 DO - 10.1016/j.jalz.2018.08.006 ID - Sandelius2019 ER - TY - JOUR AU - Brinkmalm, A. AU - Brinkmalm, G. AU - Honer, W. G. AU - Frölich, L. AU - Hausner, L. AU - Minthon, L. PY - 2014 DA - 2014// TI - SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease JO - Mol Neurodegener VL - 9 UR - https://doi.org/10.1186/1750-1326-9-53 DO - 10.1186/1750-1326-9-53 ID - Brinkmalm2014 ER - TY - STD TI - Rauchmann B-S, Sadlon A, Perneczky R. Alzheimer’s disease neuroimaging initiative. Soluble TREM2 and inflammatory proteins in Alzheimer’s disease cerebrospinal fluid. J Alzheimers Dis. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/31958095. UR - http://www.ncbi.nlm.nih.gov/pubmed/31958095 ID - ref126 ER - TY - JOUR AU - Suárez-Calvet, M. AU - Kleinberger, G. AU - Araque Caballero, M. Á. AU - Brendel, M. AU - Rominger, A. AU - Alcolea, D. PY - 2016 DA - 2016// TI - sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s disease and associate with neuronal injury markers JO - EMBO Mol Med VL - 8 UR - https://doi.org/10.15252/emmm.201506123 DO - 10.15252/emmm.201506123 ID - Suárez-Calvet2016 ER - TY - JOUR AU - Piccio, L. AU - Deming, Y. AU - Del-Águila, J. L. AU - Ghezzi, L. AU - Holtzman, D. M. AU - Fagan, A. M. PY - 2016 DA - 2016// TI - Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-016-1533-5 DO - 10.1007/s00401-016-1533-5 ID - Piccio2016 ER - TY - JOUR AU - Heslegrave, A. AU - Heywood, W. AU - Paterson, R. AU - Magdalinou, N. AU - Svensson, J. AU - Johansson, P. PY - 2016 DA - 2016// TI - Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease JO - Mol Neurodegener VL - 11 UR - https://doi.org/10.1186/s13024-016-0071-x DO - 10.1186/s13024-016-0071-x ID - Heslegrave2016 ER - TY - STD TI - Lashley T, Schott JM, Weston P, Murray CE, Wellington H, Keshavan A, et al. Molecular biomarkers of Alzheimer’s disease: progress and prospects. Dis Model Mech. 2018;11(5):dmm031781. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29739861. UR - http://www.ncbi.nlm.nih.gov/pubmed/29739861 ID - ref130 ER - TY - JOUR AU - Lleó, A. AU - Núñez-Llaves, R. AU - Alcolea, D. AU - Chiva, C. AU - Balateu-Paños, D. AU - Colom-Cadena, M. PY - 2019 DA - 2019// TI - Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s disease cerebrospinal fluid JO - Mol Cell Proteomics VL - 18 UR - https://doi.org/10.1074/mcp.RA118.001290 DO - 10.1074/mcp.RA118.001290 ID - Lleó2019 ER - TY - STD TI - Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer’s disease. EMBO Mol Med. 2019;11(12):dmm031781. Available from: https://onlinelibrary.wiley.com/doi/abs/10.15252/emmm.201911170. UR - https://onlinelibrary.wiley.com/doi/abs/10.15252/emmm.201911170 ID - ref132 ER - TY - JOUR AU - Winston, C. N. AU - Goetzl, E. J. AU - Akers, J. C. AU - Carter, B. S. AU - Rockenstein, E. M. AU - Galasko, D. PY - 2016 DA - 2016// TI - Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile JO - Alzheimer’s Dement (Amsterdam, Netherlands) VL - 3 ID - Winston2016 ER - TY - JOUR AU - Poil, S. S. AU - Haan, W. AU - Flier, W. M. AU - Mansvelder, H. D. AU - Scheltens, P. AU - Linkenkaer-Hansen, K. PY - 2013 DA - 2013// TI - Integrative EEG biomarkers predict progression to Alzheimer’s disease at the MCI stage JO - Front Aging Neurosci VL - 5 ID - Poil2013 ER - TY - JOUR AU - Zande, J. J. AU - Gouw, A. A. AU - Steenoven, I. AU - Scheltens, P. AU - Stam, C. J. AU - Lemstra, A. W. PY - 2018 DA - 2018// TI - EEG characteristics of dementia with Lewy bodies, Alzheimer’s disease and mixed pathology JO - Front Aging Neurosci VL - 10 ID - Zande2018 ER - TY - BOOK AU - Schomer, D. L. AU - Silva, F. L. PY - 2010 DA - 2010// TI - Niedermeyer’s electroencephalography. Basic principles, clinical applications, and related fields PB - Wilkins CY - Philadelphia ID - Schomer2010 ER - TY - JOUR AU - Ebersole, J. S. AU - Pedley, T. A. PY - 2003 DA - 2003// TI - Current practice of clinical electroencephalography, 3rd edn JO - Eur J Neurol VL - 10 UR - https://doi.org/10.1046/j.1468-1331.2003.00643.x DO - 10.1046/j.1468-1331.2003.00643.x ID - Ebersole2003 ER - TY - JOUR AU - Jeong, J. PY - 2004 DA - 2004// TI - EEG dynamics in patients with Alzheimer’s disease JO - Clin Neurophysiol VL - 115 UR - https://doi.org/10.1016/j.clinph.2004.01.001 DO - 10.1016/j.clinph.2004.01.001 ID - Jeong2004 ER - TY - JOUR AU - Smailovic, U. AU - Koenig, T. AU - Laukka, E. J. AU - Kalpouzos, G. AU - Andersson, T. AU - Winblad, B. PY - 2019 DA - 2019// TI - EEG time signature in Alzheimer’s disease: functional brain networks falling apart JO - NeuroImage Clin VL - 24 UR - https://doi.org/10.1016/j.nicl.2019.102046 DO - 10.1016/j.nicl.2019.102046 ID - Smailovic2019 ER - TY - JOUR AU - Smailovic, U. AU - Koenig, T. AU - Kåreholt, I. AU - Andersson, T. AU - Kramberger, M. G. AU - Winblad, B. PY - 2018 DA - 2018// TI - Quantitative EEG power and synchronization correlate with Alzheimer’s disease CSF biomarkers JO - Neurobiol Aging VL - 63 UR - https://doi.org/10.1016/j.neurobiolaging.2017.11.005 DO - 10.1016/j.neurobiolaging.2017.11.005 ID - Smailovic2018 ER - TY - JOUR AU - Gouw, A. A. AU - Alsema, A. M. AU - Tijms, B. M. AU - Borta, A. AU - Scheltens, P. AU - Stam, C. J. PY - 2017 DA - 2017// TI - EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects JO - Neurobiol Aging VL - 57 UR - https://doi.org/10.1016/j.neurobiolaging.2017.05.017 DO - 10.1016/j.neurobiolaging.2017.05.017 ID - Gouw2017 ER - TY - JOUR AU - Gianotti, L. R. R. AU - Künig, G. AU - Faber, P. L. AU - Lehmann, D. AU - Pascual-Marqui, R. D. AU - Kochi, K. PY - 2008 DA - 2008// TI - Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease JO - Psychopharmacology (Berl) VL - 198 UR - https://doi.org/10.1007/s00213-008-1111-1 DO - 10.1007/s00213-008-1111-1 ID - Gianotti2008 ER - TY - JOUR AU - Adler, G. AU - Brassen, S. PY - 2001 DA - 2001// TI - Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients JO - Neuropsychobiology. VL - 43 UR - https://doi.org/10.1159/000054902 DO - 10.1159/000054902 ID - Adler2001 ER - TY - JOUR AU - Adler, G. AU - Brassen, S. AU - Chwalek, K. AU - Dieter, B. AU - Teufel, M. PY - 2004 DA - 2004// TI - Prediction of treatment response to rivastigmine in Alzheimer’s dementia JO - J Neurol Neurosurg Psychiatry VL - 75 ID - Adler2004 ER - TY - JOUR AU - Moretti, D. V. AU - Frisoni, G. B. AU - Binetti, G. AU - Zanetti, O. PY - 2014 DA - 2014// TI - Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer’s disease JO - Front Aging Neurosci VL - 6 ID - Moretti2014 ER - TY - JOUR AU - Brassen, S. AU - Adler, G. PY - 2003 DA - 2003// TI - Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial JO - Pharmacopsychiatry VL - 36 UR - https://doi.org/10.1055/s-2003-45118 DO - 10.1055/s-2003-45118 ID - Brassen2003 ER - TY - JOUR AU - Babiloni, C. AU - Percio, C. AU - Bordet, R. AU - Bourriez, J. -. L. AU - Bentivoglio, M. AU - Payoux, P. PY - 2013 DA - 2013// TI - Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients JO - Clin Neurophysiol VL - 124 UR - https://doi.org/10.1016/j.clinph.2012.09.017 DO - 10.1016/j.clinph.2012.09.017 ID - Babiloni2013 ER - TY - JOUR AU - Scheltens, P. AU - Twisk, J. W. R. AU - Blesa, R. AU - Scarpini, E. AU - Arnim, C. A. F. AU - Bongers, A. PY - 2012 DA - 2012// TI - Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial JO - J Alzheimers Dis VL - 31 UR - https://doi.org/10.3233/JAD-2012-121189 DO - 10.3233/JAD-2012-121189 ID - Scheltens2012 ER - TY - STD TI - Scheltens P, Hallikainen M, Grimmer T, Duning T, Alida G, Teunissen C, et al. Safety, tolerability and efficacy of the glutaminyl-cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study. Alzheimers Res Ther. 2018;10(1):107. ID - ref149 ER - TY - JOUR AU - Straaten, E. C. AU - Scheltens, P. AU - Gouw, A. A. AU - Stam, C. J. PY - 2014 DA - 2014// TI - Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics JO - Alzheimers Res Ther VL - 6 UR - https://doi.org/10.1186/s13195-014-0086-x DO - 10.1186/s13195-014-0086-x ID - Straaten2014 ER - TY - JOUR AU - Waal, H. AU - Stam, C. J. J. AU - Lansbergen, M. M. M. AU - Wieggers, R. L. L. AU - Kamphuis, P. J. G. H. J. G. H. AU - Scheltens, P. PY - 2014 DA - 2014// TI - The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer’s disease: a randomised controlled study JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0086558 DO - 10.1371/journal.pone.0086558 ID - Waal2014 ER - TY - JOUR AU - Attwell, D. AU - Iadecola, C. PY - 2002 DA - 2002// TI - The neural basis of functional brain imaging signals JO - Trends Neurosci VL - 25 UR - https://doi.org/10.1016/S0166-2236(02)02264-6 DO - 10.1016/S0166-2236(02)02264-6 ID - Attwell2002 ER - TY - JOUR AU - Mosconi, L. AU - Pupi, A. AU - Leon, M. J. PY - 2008 DA - 2008// TI - Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease JO - Ann N Y Acad Sci VL - 1147 UR - https://doi.org/10.1196/annals.1427.007 DO - 10.1196/annals.1427.007 ID - Mosconi2008 ER - TY - JOUR AU - Landau, S. M. AU - Harvey, D. AU - Madison, C. M. AU - Koeppe, R. A. AU - Reiman, E. M. AU - Foster, N. L. PY - 2011 DA - 2011// TI - Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI JO - Neurobiol Aging VL - 32 UR - https://doi.org/10.1016/j.neurobiolaging.2009.07.002 DO - 10.1016/j.neurobiolaging.2009.07.002 ID - Landau2011 ER - TY - JOUR AU - Jagust, W. J. AU - Bandy, D. AU - Chen, K. AU - Foster, N. L. AU - Landau, S. M. AU - Mathis, C. A. PY - 2010 DA - 2010// TI - The Alzheimer’s Disease Neuroimaging Initiative positron emission tomography core JO - Alzheimers Dement VL - 6 UR - https://doi.org/10.1016/j.jalz.2010.03.003 DO - 10.1016/j.jalz.2010.03.003 ID - Jagust2010 ER - TY - JOUR AU - Sperling, R. A. AU - Aisen, P. S. AU - Beckett, L. A. AU - Bennett, D. A. AU - Craft, S. AU - Fagan, A. M. PY - 2011 DA - 2011// TI - Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.003 DO - 10.1016/j.jalz.2011.03.003 ID - Sperling2011 ER - TY - STD TI - van Dyck CH, Nygaard HB, Chen K, Donohue MC, Raman R, Rissman RA, et al. Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial. JAMA Neurol. 2019; Available from: http://www.ncbi.nlm.nih.gov/pubmed/31329216. UR - http://www.ncbi.nlm.nih.gov/pubmed/31329216 ID - ref157 ER - TY - STD TI - Harrison JE, Maruff P, Schembri A, Novak P, Ondrus M, Prenn-gologranc C, Katina S. Stability, reliability, validity and relationship to biomarkers of the BRADER – a new assessment for capturing cognitive changes in patients with Alzheimer’s disease. Alzheimers Res Ther. ID - ref158 ER - TY - JOUR AU - Harrison, J. E. PY - 2018 DA - 2018// TI - Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0386-7 DO - 10.1186/s13195-018-0386-7 ID - Harrison2018 ER -